XILITY
LIVE

Serial Number

98661977

Owner

Roche Molecular Systems, Inc.

Attorney

Mona Gupta

Filing Date

Jul 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

XILITY Trademark

Serial Number: 98661977

XILITY is a trademark filed by Roche Molecular Systems, Inc. on July 23, 2024. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Roche Molecular Systems, Inc. (2 trademarks)

4300 HACIENDA DRIVE
Pleasanton, CA 94588

Entity Type: 03

Trademark Details

Filing Date

July 23, 2024

Registration Date

Not Registered

Published for Opposition

March 4, 2025

Goods & Services

In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing dna, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with dna sequencing and genetic analysis

Laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; quantitative polymerase chain reaction (PCR) instrument for scientific use; scientific equipment, apparatus and instruments, namely, genome sequencers for scientific, pharmaceutical and medical research purpose; downloadable computer software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable computer software used in analyzing, managing and visualizing dna sequencing data; downloadable computer software used for preparation of nucleic acids libraries; computer hardware and downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes

Scientific research in the field of genome sequence analysis and reporting; medical research in the field of genome sequence analysis and reporting; dna screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and scientific research; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; computer services, namely, hosting an interactive web site that allows users to store, analyze and share data in the field of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing it and application systems in the field of life science; consulting services in the field of cloud computing in the field of life science; providing temporary use of online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus, instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and database systems used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of scientific analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals for scientific and medical research purposes; design and development of medical diagnostic apparatus and instruments and computer systems for use in analysis of biomolecules; scientific consulting and research services and clinical laboratory testing services in the fields of amplification, detection, sequencing and analysis of nucleic acids and the preparation of nucleic acid libraries; nucleic acid sequencing services for scientific research purposes; scientific research, namely, computational analysis of nucleic acid sequences and development of computational technologies for the analysis of nucleic acid sequences

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 20, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 20, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 20, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 10, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 9, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 9, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 9, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 29, 2025 NOAM
PUBLISHED FOR OPPOSITION
Mar 4, 2025 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2025 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 10, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 10, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 10, 2024 REAP
NEW APPLICATION ENTERED
Jul 23, 2024 NWAP